Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. (the “ Company ”) became a large accelerated filer as of December 31, 2022, which resulted in a shortened filing deadline to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “ Annual Report ”) of 60 days after fiscal year end rather than 90 days, which was the deadline when the Company was classified as an emerging growth company and non-accelerated filer. However, additional time is necessary to finalize materials required to complete the audit of the Company’s annual financial statements, including accompanying footnote disclosures. Accordingly, the Company has determined that it is unable to file its Annual Report with the U.S. Securities and Exchange Commission by the prescribed due date without unreasonable effort or expense. The Company is working diligently to file the Annual Report as soon as practicable and expects to file the Annual Report within fifteen calendar days of the prescribed due date

Soaring Eagle Acquisition Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Q1 2021 Form 10-Q”) by the prescribed due date for the reasons described below. On April 12, 2021, the Staff of the U.S. Securities and Exchange Commission (the “SEC”) issued the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”), which clarified guidance for all SPACs regarding the accounting and reporting for their warrants. Following review of the SEC Statement, the Company reevaluated the accounting treatment of its public warrants and private placement warrants (collectively, the “Warrants”) as equity, and concluded that, based on the SEC Statement, the Warrants should be, and should previously have been, classified as a liability measured at fair value, with non-cash fair value adjustments recorded in earnings at each reporting period. The Company is currently determining the extent of the SEC Statement’s impact on its financial statements, including the financial statements as of and for the fiscal quarter ended March 31, 2021 included in the Q1 2021 Form 10-Q (the “Q1 2021 Financials”). The Company is working diligently to complete the Q1 2021 Form 10-Q as soon as possible; however, given the scope of the process for determining the appropriate treatment of the Warrants in accordance with the SEC Statement, the Company is unable to complete and file the Q1 2021 Form 10-Q by the required due date of May 17, 2021 without unreasonable effort and expense. The Company expects to file such report as soon as practicable